SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of BELLUS Health Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2021 - BLU Biotech Investing
Solarvest Bioenergy Inc. Announces Non-Brokered Private Placement to Existing Shareholders and other Investors Biotech Investing
SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action Suit Against BELLUS Health Inc. Biotech Investing
BLU Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BELLUS Health Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm Biotech Investing
BLU BREAKING NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Deadline - BLU Biotech Investing
AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Adults with Active Psoriatic Arthritis Biotech Investing
Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV Biotech Investing
Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS in Latest ICER Draft Evidence Report Biotech Investing
